ctrl K

Watchlist Price Alert

Evelo Biosciences Inc. (EVLO)

OTC: EVLO · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Apr 03, 2025, 11:37 AM

Evelo Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-108.47M	-115.4M	-91.89M	-86.36M	-58.1M	-27.53M	-13.03M
Interest Income	4.67K	3.61K	n/a	1.05K	n/a	n/a	n/a
Pretax Income	-113.6M	-121.75M	-93.26M	-85.47M	-56.95M	-28.05M	-13.33M
Net Income	-114.53M	-122.18M	-93.67M	-85.66M	-53.85M	-28.05M	-13.33M
Selling & General & Admin	29.91M	31.75M	22.27M	23.23M	18.22M	7.57M	3.89M
Research & Development	78.55M	83.64M	69.62M	63.13M	39.88M	19.96M	9.13M
Other Expenses	n/a	486K	-1.37M	1.07M	1.16M	-301K	-20K
Operating Expenses	108.47M	115.4M	91.89M	86.36M	58.1M	27.53M	13.03M
Interest Expense	4.67M	3.61M	2.11M	1.05M	1.56M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	108.47M	115.4M	91.89M	86.36M	58.1M	27.53M	13.03M
Income Tax Expense	930K	428K	409K	190K	-3.09M	215K	287K
Shares Outstanding (Basic)	4.36M	2.65M	1.97M	1.6M	1.09M	187K	141K
Shares Outstanding (Diluted)	4.36M	2.65M	1.97M	1.6M	1.09M	187.54K	141.74K
EPS (Basic)	-26.28	-46.18	-47.45	-53.49	-49.25	-149.98	-94.55
EPS (Diluted)	-26.28	-46.18	-47.45	-53.49	-49.25	-149.55	-94.06
EBITDA	-106.34M	-115.4M	-91.89M	-86.36M	-58.1M	-26.7M	-12.53M
EBIT	-108.92M	-118.14M	-95.37M	-84.42M	-55.38M	n/a	n/a
Depreciation & Amortization	2.06M	2.22M	2.03M	1.76K	1.94K	834.00	495.00